FDA News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Abbreviated 510(k) project update: The Centers for Devices & Radiological Health is looking to finish, in the first quarter of 2003, collaborations with several manufacturers to draft abbreviated 510(k) summary reports, staffers say. An invitation to work with CDRH to create example summary reports serving as templates was extended to abbreviated 510(k) sponsors by the device center in June (1"The Gray Sheet" June 3, 2002, p. 3). Although CDRH has had inquiries from a number of manufacturers, not all have been fruitful, according to staffers, who are still searching for additional manufacturers with whom to collaborate on the initiative. The project is open to devices with Class II special controls final guidance documents...
You may also be interested in...
Part 11 draft guidance withdrawn
FDA rescinds November draft guidance entitled "Guidance for Industry, 21 CFR Part 11; Electronic Records; Electronic Signatures, Electronic Copies of Electronic Records," in light of Good Manufacturing Practice initiative for drugs and biologics, announced in August (1"The Gray Sheet" Aug. 26, 2002, p. 3). "The agency wishes to limit the time spent by industry reviewing and commenting on the guidance, which may no longer represent FDA's approach under the cGMP initiative," FDA explains in Feb. 4 Federal Register notice. Comments would have been due Feb. 10 (2"The Gray Sheet" Nov. 18, 2002, p. 12)...
Part 11 draft guidance withdrawn
FDA rescinds November draft guidance entitled "Guidance for Industry, 21 CFR Part 11; Electronic Records; Electronic Signatures, Electronic Copies of Electronic Records," in light of Good Manufacturing Practice initiative for drugs and biologics, announced in August (1"The Gray Sheet" Aug. 26, 2002, p. 3). "The agency wishes to limit the time spent by industry reviewing and commenting on the guidance, which may no longer represent FDA's approach under the cGMP initiative," FDA explains in Feb. 4 Federal Register notice. Comments would have been due Feb. 10 (2"The Gray Sheet" Nov. 18, 2002, p. 12)...
CLIA Waiver, Oral Fluid Claim Next For HHS-Backed OraQuick Rapid HIV Test
OraSure and FDA are discussing a CLIA waiver protocol the company has submitted for its OraQuick rapid HIV diagnostic test, which gained premarket approval Nov. 7